We also show how mutations in NAMPT can block the binding of APO866, CHS-828 and TP201565.
Furthermore, mutations in Smad4 can block nuclear translocation of this gene, which is associated with the pathogenesis of acute myelogenous leukemia [ 31].
Both EphB3 and EphA4 have been shown to be caspase targets, where D849N mutation of EphB3 or D773/774N mutation of EphA4 can block Eph-mediated cell death.
In any of these scenarios, single-point mutations can completely block the ability of a GSM to modulate processivity or as reported by others actually switch the activity of a GSM to that of an iGSM.
Although a variety of genetic mutations or chemical agents can block normal testicular descent, not all cause germ cell transformation leading to CIS-like cells and development of tumors.
If left unchecked, these lesions can block ongoing replication, leading to mutations, genome rearrangements, and even cell death [1].
Artificial mutations in the terminal loop of miRNAs, such as miR-31 and miR-30, can block miRNA maturation [ 43].
Scientists have long known that people who lack CCR5 because of genetic mutations hardly ever get the virus and that the body harbors another molecule, Rantes, that can block the virus by sticking to CCR5.
Activating mutations of KRAS found in human PDAC (point mutations at codon G12 (98% of all KRAS mutations in PDAC), G13 and Q61) impair intrinsic GTPase activity of the KRAS protein and can block the interaction between KRAS and GAPs.
Indeed, these lesions can block genome integrity and if not repaired or repaired incorrectly lead to mutations or aberrations threatening cell viability.
